Key regions: United Kingdom, Canada, Japan, Europe, China
The Dermatological Drugs market in Mongolia has experienced steady growth in recent years.
Customer preferences: Mongolian customers have shown a growing interest in skincare products and treatments, leading to an increased demand for dermatological drugs. This trend is in line with the global rise in skincare awareness and the growing importance of appearance in modern society.
Trends in the market: The dermatological drugs market in Mongolia is characterized by the dominance of multinational pharmaceutical companies, which have a strong presence in the country. These companies have been able to leverage their global expertise and resources to offer a wide range of dermatological drugs to Mongolian customers. Additionally, there has been a growing trend towards the use of natural and organic ingredients in skincare products, which has led to the development of new dermatological drugs that are formulated with these ingredients.
Local special circumstances: Mongolia's harsh climate and high altitude can lead to a range of skin problems, including dryness, sensitivity, and sun damage. As a result, there is a high demand for dermatological drugs that can address these issues. Additionally, Mongolia's traditional nomadic lifestyle can lead to exposure to the elements and a lack of access to modern healthcare facilities, making dermatological drugs a popular choice for treating skin problems.
Underlying macroeconomic factors: Mongolia's economy has been growing steadily in recent years, driven by the country's mining sector. This growth has led to an increase in disposable income and a growing middle class, which has in turn led to increased spending on healthcare and skincare products. Additionally, Mongolia's strategic location between China and Russia has made it an attractive market for multinational pharmaceutical companies looking to expand their presence in the region.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
